When U.S. R&D funding drops, where does the talent go?
News about U.S. R&D budget cuts keeps making headlines, but our team is viewing it from a different angle. The common perception is that 'U.S. science is shrinking.' However, from an export and trade perspective, this is a clear signal of talent migration. Following NIH and NSF budget cuts in 2025, postdocs and researchers who lost their positions are moving to Europe, Canada, South Korea, and Singapore.
We’ve actually encountered instances during our buyer research where U.S. postdocs have started interviewing with South Korean startups.
On LinkedIn, we’ve begun to notice a pattern of 'ex-NIH postdoc' profiles gravitating toward biotech and materials startups. As NIH and NSF budgets see historic cuts, the exodus of displaced researchers toward Europe, Canada, and South Korea has even been highlighted in Nature.
This isn't just an academic issue; when these experts flow into startups, it fundamentally transforms the company’s technological capabilities. A quiet reorganization of the supply chain is underway. Looking at one biotech startup we contacted, we found their core research team composition had shifted significantly compared to last year.
We are currently testing ways to use tools like Rinda to link these talent migration signals with buyer prospecting, and the results have been quite promising.
Has your company considered exploring collaborations with international research talent? If so, we’d love to hear in the comments which field you're in 👇
#Export #GlobalSales #Trade #BuyerProspecting #B2B